The Stanford development is the first time a complete working circuit has been created and publicly demonstrated, suggesting that the material may indeed live up to its promise.
Homo-oligomerization of μ, δ, and κ opioid receptors has been demonstrated, suggesting a critical functional role for receptor receptor interactions.
The specific association of immunonanocapsules to cells overexpressing TfR was thus demonstrated, suggesting their ability to deliver drugs to the brain.
By the method of Lohmar et al.7, the presence of d-glucuronic acid in the residue from hydrolysis of a glucuronide with β-glucuronidase has been demonstrated, suggesting that this enzyme is distinct from the system causing synthesis in Lipschitz and Beuding's experiments.
More importantly, well distinguishing Tyr from ascorbic acid, dopamine, uric acid, epinephrine was also demonstrated, suggesting an excellent anti-interference ability of this Tyr sensor in the physiological system.
This is the second species for which the protective effect of hypoxia on copper toxicity prior to hatching, followed by its exacerbating effect after hatching is demonstrated, suggesting the hypothesis that this pattern may be common for teleost species.
Peak power density as high as 246 mW cm−2 is obtained at 700 °C, and good tolerance to complete redox cycles is also initially demonstrated, suggesting that this design is feasible for high performance metal-supported SOFCs.
No long-term survival difference in MCD patients treated with debulking surgery, immunosuppressive therapy, or a combination of both has been demonstrated, suggesting that debulking surgery could be potentially beneficial for the treatment of MCD [8].
Differing activity patterns depending on the acupoint site were demonstrated, suggesting that neurological effects vary with the site of stimulation.
